The results of a study conducted by Andre et al (7), which assessed phosphorylated Akt (pAkt) expression in 823 patients with early-stage breast cancer, indicated that the overexpression of pAkt was not correlated with patient prognosis. This evidence concerns the gene AKT1 and breast cancer.